Indriķis Liepa heads IP, IT and Regulatory practice group and is among the leading practitioners in pharmacy law. He has a vast track record of over 15 years in consulting the leading local and foreign financial, food production, IT and other companies. Indrikis has substantial skills base in arranging major local M&A deals and significant investment projects.
Indriķis has extensive knowledge on pharmacy law and is rendering both - daily legal support to numerous pharmacy undertakings and has also advised on major pharmaceutical industry headline deals.
- Corporate/Commercial – Band 4, Chambers Global 2020
- Corporate/Commercial – Band 4, Chambers Europe 2020
- Languages
- Latvian, English, Russian
- Education & membership
- Master’s degree in Law, Riga Graduate School of Law, Riga, Latvia (2003)
- Lawyer’s qualification, University of Latvia, Riga, Latvia (2002)
- Latvian Bar Association (since 2002)
- Institute for Corporate Sustainability and Responsibility
- International Association of Young Lawyers
- OECD Latvian task group
- Publications
- A Solution to Insufficiencies in Supply of Medicines in Latvia
- Scrutiny of Industry Practices by the Competition Authority Continues
- Pharmacy Law News - July 2019
- eVeselība: the magic eHealth solution for Latvia?
- Tax Reform in Latvia Set for Launch in 2018
- Tax Flash News – April 2017
- Comparative Investment Guide to the Baltics - July 2016
- COBALT advised capital300 and Chalfen Ventures on a EUR 5 million investment into Lokalise
- COBALT advises Roche Latvija on the Acquisition of Medilink distribution business
- COBALT Advises Prezi in Acquiring Data Visualization Company Infogram
- COBALT advised Anttila on different corporate governance matters and management structure
- COBALT advised VAS Valsts nekustamie ipasumi in acquisition of shares in SIA Biroju centrs Ezerparks
- COBALT represents Konekesko Latvija in tax dispute with the State Revenue Service
- Tax advice to Octapharma Nordic AB
- COBALT represents Tavex, the largest investment gold dealer in Northern Europe
- Representation of Abbott Laboratories Baltics
- COBALT advises H&M on Latvian tax matters
- General legal assistance to Mylan
- Legal assistance to Nordic Sugar AS
- General legal assistance to GlaxoSmithKline
- COBALT advises Abbott Laboratories on sale to Mylan of non-U.S. developed markets specialty and branded generics business
- General legal assistance to Roche
- COBALT advises Association of Biopharmaceutical Medicinal Products in Latvia (includes AbbVie, Merck Serono, Roche and others) on amendments to legal pharma-regulations
- General legal assistance to Abbott Laboratories
- General legal assistance to Abbvie
- COBALT advises Franklin Templeton Investments in acquisition of majority stake in SIA Storent Holding
- COBALT advises Merck & Co., Inc in sale of Merck’s consumer care business
- COBALT represents minority shareholder interests in acquisition of 60% stake in Ask.fm by Dutch company IAC Search Europe B.V.
- Legal advice to Roche Latvia on implementation of a distribution scheme
- COBALT provides legal assistance to SIA FMS on company sale to major North European IT company Visma Group
- COBALT advises Wikimedia on Latvian tax matters
- Tax advice to Homburg Invest Inc. in global corporate restructuring process
- COBALT advises Canadian stock listed company within implementation of a restructuring plan governed under Canadian CCAA rules in the Baltics
- COBALT advises Association for Lymphoma Patients’ Support and the Rare Disease Association Caladrius
Indriķis Liepa frequently assists clients from a range of sectors with M&A transactions. He is particularly known for his expertise in pharmaceutical law. Clients describe him as ‘business-minded.’